Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,728.50
Bid: 1,727.00
Ask: 1,728.00
Change: 23.50 (1.38%)
Spread: 1.00 (0.058%)
Open: 1,705.00
High: 1,729.50
Low: 1,695.50
Prev. Close: 1,705.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

US STOCKS-Wall St flat after retail sales, Nasdaq edges higher

Mon, 13th May 2013 16:41

* Core U.S. retail sales rise 0.5 percent in April

* Yum Brands falls as monthly Chinese sales drop

* Crude oil falls, pressuring energy companies

* Indexes: Dow down 0.2 pct, S&P up 0.1 pct, Nasdaq up 0.3pct

By Ryan Vlastelica

NEW YORK, May 13 (Reuters) - U.S. stocks were mostly flat onMonday as investors paused following a rally that took indexesto record highs, though a strong read on retail sales limiteddeclines and the Nasdaq ticked up on a rally in Netflix.

The S&P 500 has jumped more than 14 percent so far thisyear, a rally that has repeatedly taken it to record intradayand closing highs without sustained declines. While thelong-term trend is still viewed as positive, many analysts saidthe momentum could wane in the absence of positive catalysts.

Retail sales rose 0.1 percent in April, better than the 0.3percent drop that had been expected, and returning to growthfollowing a decline in March.

Excluding autos, gasoline and building materials, core salesrose 0.5 percent. Retail sales account for about 30 percent ofU.S. consumer spending.

"Recent data has been weak, so to see some sturdiness isimportant and needed in order for us to move materially higher,"said Mark Luschini, chief investment strategist at JanneyMontgomery Scott in Philadelphia. "But given the strength we'vehad over the past few weeks, it isn't surprising that trading isa bit indifferent today."

The S&P 500 managed its third straight weekly gainlast week, reaching a record high on Friday. The benchmark had a five-day streak of record closing highs before settling loweron Thursday.

The Dow Jones industrial average was down 24.04points, or 0.16 percent, at 15,094.45. The Standard & Poor's 500Index was up 1.41 points, or 0.09 percent, at 1,635.11.The Nasdaq Composite Index was up 8.40 points, or 0.24percent, at 3,444.99.

Netflix Inc jumped 4.2 percent to $226.81 as one ofthe biggest advancing stocks in the S&P 500, helping to keep theNasdaq in slightly positive territory.

Other data showed business inventories were unchanged inMarch for a second straight month versus expectations of 0.3percent rise, suggesting restocking could help second-quartereconomic growth.

Crude oil fell 0.7 percent to $95.39 per barrel,pressured by a drop to an eight-month low in demand in China.

Luschini, who helps oversee $58 billion in assets, said thedrop in oil and gasoline prices contributed to the strong readon retail sales, "so it is helpful to see those remain tame.

"However, if we dip below $90 a barrel, that will hurt theenergy sector and could be a signal of lower global growth."

Consol Energy fell 2 percent to $34.14 whileNational Oilwell Varco was off 1.4 percent at $67.27.

Yum Brands Inc fell 2.6 percent to $68.54. After themarket closed on Friday, the fast food chain operator posted asteep decline in Chinese April sales.

With 90 percent of the S&P 500 having reported, 67.2 percentof companies have topped earnings expectations, according toThomson Reuters data, an amount that is even with the averageover the past four quarters. Only 46.9 percent have beatenrevenue expectations, under the 52 percent average over the pastfour quarters.

Elan agreed to a $1 billion deal to buy 21percent of the royalties that U.S. company Theravance receives from GlaxoSmithKline for itsrespiratory drugs. Theravance shares jumped 15 percent to$40.33.

U.S.-listed shares of Perion Network surged 12percent to $14.10 after the Israeli consumer Internet companyposted first-quarter earnings.

SoftBank Corp has told banks that their financingof Dish Network Corp's $25.5 billion rival offer forSprint Nextel Corp could hurt their chances of landing arole in a highly anticipated public offering of Chinesee-commerce giant Alibaba Group Holding Ltd, two sources familiarwith the situation said.

Sprint shares dipped 1.6 percent to $7.24 while Dish lost1.7 percent to $38.51.

More News
Today 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
Today 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.